The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

被引：0
|
作者：
Lee, Ho Sup
Min, Chang-Ki
Lee, Je-Jung
Kim, Kihyun
Yoon, Sung-Soo
Kim, Inho
Bang, Soo-Mee
Kim, Jin Seok
Eom, Hyeon-Seok
Yoon, Dok Hyun
Lee, Yoojin
Shin, Ho-Jin
Park, Yong
Jo, Jae-Cheol
Lee, Won-Sik
Do, Young Rok
Mun, Yeung-Chul
Lee, Mark Hong
Kim, Hyo Jung
Kim, Sung-Hyun
Kim, Min Kyoung
Lim, Sung-Nam
Cho, Su-Hee
Park, Seong Kyu
Lee, Joon-ho
Lee, Jae Hoon
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3130
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP)
    Lee, Ho Sup
    Min, Chang Ki
    Kim, Kihyun
    Lee, Je-Jung
    Bang, Soo-Mee
    Kim, Jin Seok
    Eom, Hyeon Seok
    Lee, Jae Hoon
    Yoon, Do Hyun
    Kim, Inho
    Shin, Ho-Jin
    Park, Yong
    Jo, Jae-Cheol
    Lee, Won Sik
    Mun, Yeung-Chul
    Kim, Hyo Jung
    Park, Seong Kyu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E74 - E75
  • [2] The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
    Jo, Jae-Cheol
    Lee, Ho Sup
    Kim, Kihyun
    Lee, Je-Jung
    Yoon, Sung-Soo
    Bang, Soo-Mee
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Yoon, Dok Hyun
    Lee, Yoojin
    Shin, Ho-Jin
    Park, Yong
    Lee, Won Sik
    Do, Young Rok
    Mun, Yeung-Chul
    Lee, Mark Hong
    Kim, Hyo Jung
    Kim, Sung-Hyun
    Kim, Min Kyoung
    Lim, Sung-Nam
    Cho, Su-Hee
    Park, Seong Kyu
    Yi, Jun Ho
    Lee, Jae Hoon
    Kim, Jinmi
    Min, Chang-Ki
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 309 - 319
  • [3] The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
    Jae-Cheol Jo
    Ho Sup Lee
    Kihyun Kim
    Je-Jung Lee
    Sung-Soo Yoon
    Soo-Mee Bang
    Jin Seok Kim
    Hyeon-Seok Eom
    Dok Hyun Yoon
    Yoojin Lee
    Ho-Jin Shin
    Yong Park
    Won Sik Lee
    Young Rok Do
    Yeung-Chul Mun
    Mark Hong Lee
    Hyo Jung Kim
    Sung-Hyun Kim
    Min Kyoung Kim
    Sung-Nam Lim
    Su-Hee Cho
    Seong Kyu Park
    Jun Ho Yi
    Jae Hoon Lee
    Jinmi Kim
    Chang-Ki Min
    Annals of Hematology, 2020, 99 : 309 - 319
  • [4] Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
    Lee, Ho Sup
    Kim, Kihyun
    Kim, Seok Jin
    Lee, Je-Jung
    Kim, Inho
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Yoon, Dok Hyun
    Suh, Cheolwon
    Shin, Ho-Jin
    Mun, Yeung-Chul
    Kim, Min Kyoung
    Lim, Sung-Nam
    Choi, Chul Won
    Kang, Hye Jin
    Yoon, Sung-Soo
    Min, Chang-Ki
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (04) : 413 - 421
  • [5] Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
    Lee, Ho Sup
    Min, Chang-Ki
    Kim, Kihyun
    Kim, Seok Jin
    Lee, Je-Jung
    Kim, Inho
    Yoon, Sung-Soo
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Yoon, Dok Hyun
    Suh, Cheolwon
    Shin, Ho-Jin
    Mun, Yeung-Chul
    Kim, Min Kyoung
    Lim, Sung-Nam
    Choi, Chul Won
    Kang, Hye Jin
    BLOOD, 2019, 134
  • [6] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
  • [7] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [8] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [9] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [10] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
12345